FAMILIAL CANCER CLINIC

INTERNATIONAL RESEARCH

Breast Cancer Risk and Breast-Cancer-Specific Mortality following Risk-Reducing Salpingo-Oophorectomy in BRCA Carriers: A Systematic Review and Meta-Analysis

Gaba F, Blyuss O, Tan A, Munblit D, Oxley S, Khan K, Legood R, Manchanda R.

BRCA1/ BRCA2 mutation spectrum analysis in South Asia: a systematic review

Kharel S, Shrestha S, Yadav S, Shakya P, Baidya S, Hirachan S.

Editorial: Hereditary Breast and Ovarian Cancer: Current Concepts of Prevention and Treatment

Grabenstetter A, Lazaro C, Turashvili G. Editorial

Genetic, clinic and histopathologic characterization of BRCA-associated hereditary breast and ovarian cancer in southwestern Finland

Pallonen, T.AS., Lempiäinen, S.M.M., Joutsiniemi, T.K. et al

Hereditary breast and ovarian cancer (HBOC): review of its molecular characteristics, screening, treatment, and prognosis

Yoshida, R.

Patient and Clinician Decision Support to Increase Genetic Counseling for Hereditary Breast and Ovarian Cancer Syndrome in Primary Care: A Cluster Randomized Clinical Trial

Kukafka R, Pan S, Silverman T, et al.

Identification of women at risk of hereditary breast-ovarian cancer among participants in a population-based breast cancer screening

Bonelli L, Valle I, Rebora I, et al.

Management of hereditary breast and ovarian cancer

Yamauchi H, Takei J.

Prevalence of hereditary breast and ovarian cancer (HBOC) predisposition gene mutations among 882 HBOC high-risk Chinese individuals

Shao D, Cheng S, Guo F, et al.

Analysis of hereditary cancer syndromes by using a panel of genes: novel and multiple pathogenic mutations

Tsaousis GN, Papadopoulou E, Apessos A, et al.

BRCA and Breast Cancer-Related High-Penetrance Genes

Han SA, Kim SW.

Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer

Andrew N.J. Tutt, M.B., Ch.B., Ph.D., Judy E. Garber, M.D., M.P.H., et al.

Breast Cancer Risk Genes — Association Analysis in More than 113,000 Women

 Breast Cancer Association Consortium

Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation

Mark Robson, M.D., Seock-Ah Im, M.D., Ph.D., Elżbieta Senkus, M.D., Ph.D., Binghe Xu, M.D., Ph.D., Susan M ,et al.

A Population-Based Study of Genes Previously Implicated in Breast Cancer

Chunling Hu, M.D., Ph.D., Steven N. Hart, Ph.D., Rohan Gnanaolivu, M.S., Hongyan Huang, Ph.D., Kun Y. Lee,et al.

Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer

Talia Golan, M.D., Pascal Hammel, M.D., Ph.D., Michele Reni, M.D., Eric Van Cutsem, M.D., Ph.D., Teresa Macarulla, M.D., ,et al.

Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer

A.N.J. Tutt, J.E. Garber, B. Kaufman, G. Viale, D. Fumagalli, P. Rastogi,
R.D. Gelber, E. de Azambuja, A. Fielding, J. Balmaña, S.M. Domchek,
K.A. Gelmon, S.J. Hollingsworth, L.A. Korde ,et al.

BRCA1/2 Mutations in Vietnamese Patients with Hereditary Breast and Ovarian Cancer Syndrome

Le TN, Tran VK, Nguyen TT, et al

Adjuvant Olaparib in BRCA-Mutated Breast Cancer

A.N.J. Tutt 

Germline mutations in Chinese ovarian cancer with or without breast cancer

Kwong A, Ho CYS, Shin VY, et al.

Editorial: Hereditary Breast and Ovarian Cancer: Current Concepts of Prevention and Treatment

Grabenstetter A, Lazaro C, Turashvili G.

Genetic, clinic and histopathologic characterization of BRCA-associated hereditary breast and ovarian cancer in southwestern Finland

Pallonen, T.AS., Lempiäinen, S.M.M., Joutsiniemi, T.K. et al.

Hereditary breast and ovarian cancer (HBOC): review of its molecular characteristics, screening, treatment, and prognosis

Reiko Yoshida

Patient and Clinician Decision Support to Increase Genetic Counseling for Hereditary Breast and Ovarian Cancer Syndrome in Primary Care A Cluster Randomized Clinical Trial

Kukafka R, Pan S, Silverman T, et al.

Identification of women at risk of hereditary breast-ovarian cancer among participants in a population-based breast cancer screening

Bonelli L, Valle I, Rebora I, et al.

Management of hereditary breast and ovarian cancer

Yamauchi H, Takei J.

Prevalence of hereditary breast and ovarian cancer (HBOC) predisposition gene mutations among 882 HBOC high‐risk Chinese individuals

Shao D, Cheng S, Guo F, et al.

Analysis of hereditary cancer syndromes by using a panel of genes: novel and multiple pathogenic mutations

Tsaousis GN, Papadopoulou E, Apessos A, et al.

BRCA1/2 Mutations in Vietnamese Patients with Hereditary Breast and Ovarian Cancer Syndrome

Le TN, Tran VK, Nguyen TT, et al.

Screening of over 1000 Indian patients with breast and/or ovarian cancer with a multi-gene panel: prevalence of BRCA1/2 and non-BRCA mutations. Breast Cancer Res Treat

Singh J, Thota N, Singh S, et al.

BRCA and Breast Cancer-Related High-Penetrance Genes

Han SA, Kim SW.

Next Generation Sequencing-Based Germline Panel Testing for Breast and Ovarian Cancers in Pakistan

Tariq H, Gul A, Khadim T, et al.